FN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Fabrinet (FN) shows strong financial performance and positive analyst sentiment, but the recent significant price drop (-8.69% in regular market and -1.31% post-market) suggests caution. Given the user's long-term investment preference and beginner status, it is advisable to hold off on buying until the stock stabilizes or shows signs of recovery.
The technical indicators are mixed. While the MACD is positive and contracting, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200), the RSI is neutral at 57.589, and the stock is trading below its pivot level of 543.294. The recent price drop is concerning, and the stock is nearing its S1 support level of 477.51.
Hedge funds are significantly increasing their positions, with an 824.23% increase in buying over the last quarter.
Strong financial performance in Q2 2026, with revenue up 35.90% YoY, net income up 30.00% YoY, and EPS up 30.67% YoY.
Analysts have raised price targets recently, with Wolfe Research upgrading the stock to Outperform and Barclays raising its price target to $548.
Significant price drop of -8.69% during the regular market session and -1.31% post-market.
No recent news to provide clarity on the price drop or potential recovery.
Insider trading activity is neutral, with no significant trends.
Fabrinet reported strong Q2 2026 financials, with revenue increasing by 35.90% YoY to $1.13 billion, net income up 30.00% YoY to $112.63 million, EPS up 30.67% YoY to 3.11, and gross margin improving slightly to 12.15%.
Analysts are generally positive on Fabrinet. Wolfe Research upgraded the stock to Outperform with a $540 price target, citing a favorable industry environment. Barclays raised its price target to $548, and Susquehanna increased its target to $570, highlighting opportunities in AI and optical networking. However, B. Riley remains Neutral, citing a premium valuation with limited room for error.
